Exceptional protection is always an elite choice.
ELEVATE YOUR PROTOCOL WITH THE INDUSTRY’S #1 VACCINE PORTFOLIO.1
Take comfort in the facts:
• Backed by 10+ licensing and post-licensing studies • No viral shedding via equine influenza virus (EIV) challenge2 • Demonstrated at least 6 months duration of immunity (DOI) for Clade 1 EIV
• Over 12 million doses administered1 • The only vaccine with 2005 West Nile isolate
LEARN MORE AT
THEARTOFHORSE.COM
1 Data on file at Boehringer Ingelheim 2 Data on file at Boehringer Ingelheim VETERA®
Reserved. US-EQU-0046-2023-A is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license. ©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76
